mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules.

Saved in:
Bibliographic Details
Title: mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules.
Authors: Hosseini Kakroudi M; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran., Rezvanimehr A; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Zolfaghari K; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Baghaei-Shiva G; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Abbasi H; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Pourashory M; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Yazdanpanah N; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran., Saleki K; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran., Rezaei N; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. rezaei_nima@tums.ac.ir.; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@tums.ac.ir.; Department of Immunology, Children's Medical Center Hospital, Tehran University of Medical Sciences, Dr. Qarib St, Keshavarz Blvd, Tehran, 14194, Iran. rezaei_nima@tums.ac.ir.
Source: Discover oncology [Discov Oncol] 2026 Apr 04; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 04.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2730-6011
DOI:10.1007/s12672-026-04811-w